Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura - Related Studies

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

This study is ongoing, but not recruiting participants.

Study NCT00004920. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Malignant Mesothelioma

2	Additional conditions recognized in this trial
		Mesothelioma

3	More general conditions related to this trial
		Adenoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Glandular and Epithelial
		Neoplasms, Mesothelial

4	Interventions listed in this trial
		cisplatin
		raltitrexed

5	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		European Organization for Research and Treatment of Cancer